0001209191-20-018991.txt : 20200313 0001209191-20-018991.hdr.sgml : 20200313 20200313172903 ACCESSION NUMBER: 0001209191-20-018991 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200312 FILED AS OF DATE: 20200313 DATE AS OF CHANGE: 20200313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Murray Christine CENTRAL INDEX KEY: 0001600361 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36183 FILM NUMBER: 20714131 MAIL ADDRESS: STREET 1: C/O ACHAOGEN, INC. STREET 2: 7000 SHORELINE COURT, SUITE 371 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc. CENTRAL INDEX KEY: 0001305253 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 361004130 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-279-9845 MAIL ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: Celladon Corp DATE OF NAME CHANGE: 20041005 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-12 0 0001305253 Eiger BioPharmaceuticals, Inc. EIGR 0001600361 Murray Christine C/O EIGER BIOPHARMACEUTICALS, INC. 2155 PARK BLVD. PALO ALTO CA 94306 1 0 0 0 Common Stock 2020-03-12 4 A 0 5000 0.00 A 5000 D Stock Option (Right to Buy) 5.60 2020-03-12 4 A 0 10000 0.00 A 2030-03-11 Common Stock 10000 10000 D Represents shares underlying Restricted Stock Units award that will vest on the first anniversary of the grant date of March 12, 2020. The option vests in equal monthly installments over 12 months measured from March 12, 2020 subject to Reporting Person's continuous service status as of each such date. /s/ Sriram Ryali, Attorney-in-Fact 2020-03-13